Eton Pharmaceuticals, Inc. (ETON)
57.55
+0.47
(+0.82%)
USD |
NASDAQ |
Sep 14, 16:00
57.55
0.00 (0.00%)
After-Hours: 16:59
Eton Pharmaceuticals Price : 57.55 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 58.99 | 59.98 | 56.44 | 57.08 | 323593.0 |
| Sep 10, 2026 | 58.78 | 59.55 | 57.61 | 57.88 | 281699.0 |
| Sep 09, 2026 | 58.91 | 60.43 | 58.66 | 58.83 | 373711.0 |
| Sep 08, 2026 | 57.37 | 59.98 | 56.11 | 59.34 | 396341.0 |
| Sep 04, 2026 | 59.87 | 59.94 | 56.93 | 58.45 | 521604.0 |
| Sep 03, 2026 | 61.96 | 62.39 | 59.70 | 59.90 | 497556.0 |
| Sep 02, 2026 | 61.15 | 62.91 | 59.59 | 61.96 | 577766.0 |
| Sep 01, 2026 | 60.41 | 61.72 | 59.89 | 60.43 | 564615.0 |
| Aug 31, 2026 | 59.04 | 60.61 | 58.24 | 60.44 | 768010.0 |
| Aug 28, 2026 | 61.98 | 62.12 | 58.33 | 59.78 | 588746.0 |
| Aug 27, 2026 | 62.50 | 63.26 | 61.88 | 62.67 | 445966.0 |
| Aug 26, 2026 | 63.60 | 63.60 | 61.03 | 62.62 | 443501.0 |
| Aug 25, 2026 | 64.55 | 65.50 | 62.00 | 63.05 | 536952.0 |
| Aug 24, 2026 | 63.90 | 66.37 | 62.90 | 64.43 | 801541.0 |
| Aug 21, 2026 | 59.76 | 64.00 | 59.76 | 63.47 | 640789.0 |
| Aug 20, 2026 | 60.99 | 62.58 | 59.59 | 59.91 | 586529.0 |
| Aug 19, 2026 | 63.55 | 63.83 | 60.06 | 61.48 | 608921.0 |
| Aug 18, 2026 | 61.10 | 63.56 | 60.00 | 63.43 | 872479.0 |
| Aug 17, 2026 | 59.15 | 62.87 | 56.65 | 61.73 | 1.285M |
| Aug 14, 2026 | 54.93 | 59.79 | 53.01 | 58.86 | 2.318M |
| Aug 13, 2026 | 42.11 | 43.19 | 40.66 | 40.80 | 696938.0 |
| Aug 12, 2026 | 41.99 | 43.18 | 41.18 | 41.58 | 463093.0 |
| Aug 11, 2026 | 43.60 | 43.60 | 40.61 | 42.05 | 584578.0 |
| Aug 10, 2026 | 44.50 | 45.35 | 43.12 | 43.67 | 370019.0 |
| Aug 07, 2026 | 46.09 | 46.60 | 44.55 | 44.60 | 277988.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Nektar Therapeutics | 68.43 |
| Pfizer Inc. | 27.76 |
| Elite Pharmaceuticals, Inc. | 0.263 |
| Daré Bioscience, Inc. | 0.7344 |
| Liquidia Corp. | 65.30 |
Price Related Metrics
| PE Ratio | 152.13 |
| PS Ratio | 16.69 |
| Price to Book Value | 34.95 |
| Earnings Yield | 0.66% |
| Market Cap | 1.628B |
| Operating PE Ratio | 106.75 |
| Normalized PE Ratio | 150.14 |